Gilead Sciences, Inc. (NASDAQ:GILD) Position Reduced by Atria Investments Inc

Atria Investments Inc decreased its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 0.7% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 72,826 shares of the biopharmaceutical company’s stock after selling 485 shares […]

Related Keywords

United States ,Canada ,Johanna Mercier ,Andrewd Dickinson ,Complera Eviplera ,Baker Tilly Wealth Management ,News Ratings For Gilead Sciences Daily ,Securities Exchange Commission ,Nasdaq ,Intercontinental Wealth Advisors ,Gilead Sciences Inc ,Nilsine Partners ,Royal Bank ,Altshuler Shaham Ltd ,Gilead Sciences Price Performance ,Quarter For Gilead Sciences ,Gilead Sciences ,Barclays ,Exchange Commission ,Atria Investments Inc ,Deutsche Bank Aktiengesellschaft ,Free Report ,Investments Inc ,Shaham Ltd ,Wealth Advisors ,Tilly Wealth Management ,Lansing Street Advisors ,Street Advisors ,Bank Aktiengesellschaft ,Get Free Report ,Gilead Sciences Daily ,Nasdaq Gild ,Gild ,Medical ,37555810 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,